Business
Clinitech Laboratory Limited Press Release Sep 27 2025
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jagdish Umakant Nayak
About this update from Clinitech Laboratory Limited
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jagdish Umakant Nayak View Attachment
View stock analysis, news, and events for Clinitech Laboratory Limited